Stability-Indicating RP-HPLC Method for the Determination of Vildagliptin in Tablets: Application to Degradation Kinetics
Keywords:
Vildagliptin, stability indicating method, degradation, kinetic studyAbstract
We developed and validated a stability-indicating high performance liquid chromatography (HPLC) method for the quantitative determination of vildagliptin in tablet formulations, focusing on its degradation products. The method was developed following the ICH guidelines encompassing precision, accuracy, specificity, linearity, and robustness. Vildagliptin exhibited remarkable linearity (R2 = 0.999) and highly sensitive detection and quantification limits determined at 0.05 and 0.5 μg/ml, respectively. Precision, assessed through intra-day (0.48 %) and inter-day (0.975%) analyses, demonstrated % RSD values within 2.0%, while accuracy was confirmed with average recoveries ranging from 99.54% to 101.5%. Robustness testing revealed acceptable % RSD values when varying mobile phase parameters. Then, stress studies revealed vildagliptin's susceptibility to acid, base, and oxidative degradation, while maintaining stability under heat and photolytic conditions. Degradation kinetics analysis indicated pseudo-first-order kinetics for degradation in acid, base, and oxidative agents. The half-life (t1/2), calculated using the Arrhenius plot, of the drug indicates the highest stability (t1/2, 990 h) in the heated condition and the lowest stability (t1/2, 115.5 h) in the acidic environment. The method's application extends to studying vildagliptin stability, suggesting protective measures during storage, particularly in oxidative, acidic, and basic environments, to ensure product stability and efficacy.
Dhaka Univ. J. Pharm. Sci. 25(1): 11-19, 2026 (June)
0
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Dhaka University Journal of Pharmaceutical Sciences

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
© Dhaka University Journal of Pharmaceutical Sciences

Articles in DUJPS are licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.